A worldwide registry collecting tumor records and tissue for DIPG and DMG
Original title: International Diffuse Intrinsic Pontine Glioma (DIPG)/Diffuse Midline Glioma (DMG) Registry and Repository
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is given, and this study collects records and samples instead of testing a treatment.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study gathers health records and tumor samples so doctors can learn more about DIPG and DMG.
Who this trial is for. This study is for people who have been diagnosed with DIPG or DMG. It does not test a drug. It collects health information, scans, and tumor tissue in one central place.
Where it stands. This study has not reported results. It is building a shared store of records, scans, and tissue samples. Researchers plan to use the samples to study how these tumors work at the molecular level. Those answers are not in yet.
What this means, and what it doesn't
What it could mean: Taking part does not treat the tumor. It gives researchers around the world the same information to work from. The hope is that this leads to better ways to diagnose and treat these tumors later. Someone who fits might ask their care team about it.
What it doesn't mean: A study is a test, not a proven treatment. Joining does not mean you or your child will be helped. This study does not offer a new treatment at all. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 26, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.